{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T13:26:02Z","timestamp":1781184362894,"version":"3.54.1"},"reference-count":112,"publisher":"CSIRO Publishing","issue":"2","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":4656,"URL":"https:\/\/doi.org\/10.1071\/journalslicense"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1,29]]},"abstract":"<jats:p>The ovary is a key tissue in the study of physiological neo-vascularisation in the adult and its study has highlighted important molecules involved in the regulation of angiogenesis in vivo. These include vascular endothelial growth factor, delta-like ligand 4, thrombospondin-1, prokineticin-1 and prostaglandin E2. Targeting these molecular pathways has therapeutic potential and their manipulation has an increasing preclinical and clinical role in the management of the pathological ovary. Targeting angiogenic pathways has utility in the promotion of ovarian angiogenesis to improve tissue and follicle survival and function as well as the prevention and management of ovarian hyperstimulation syndrome. There is a theoretical possibility that targeting angiogenesis may improve the function of the polycystic ovary and a real role for targeting angiogenesis in ovarian cancer.<\/jats:p>","DOI":"10.1071\/rd12112","type":"journal-article","created":{"date-parts":[[2012,8,26]],"date-time":"2012-08-26T19:55:18Z","timestamp":1346010918000},"page":"362-371","source":"Crossref","is-referenced-by-count":23,"title":["Targeting angiogenesis in the pathological ovary"],"prefix":"10.1071","volume":"25","author":[{"given":"W. Colin","family":"Duncan","sequence":"first","affiliation":[{"name":"AMRC Centre for Reproductive Health, The Queen\u2019s Medical Research Institute, The University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK."},{"name":"BCorresponding author. Email: w.c.duncan@ed.ac.uk"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Nio-Kobayashi","sequence":"additional","affiliation":[{"name":"AMRC Centre for Reproductive Health, The Queen\u2019s Medical Research Institute, The University of Edinburgh, 47 Little France Crescent, Edinburgh EH16 4TJ, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"67","published-online":{"date-parts":[[2012,8,27]]},"reference":[{"key":"2025102819390110300_R1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/J.EJOGRB.2004.07.024","article-title":"Vascular endothelial growth factor and insulin-like growth factor-1 in polycystic ovary syndrome and their relation to ovarian blood flow.","volume":"118","author":"Abd El Aal","year":"2005","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"2025102819390110300_R2","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/J.FERTNSTERT.2009.01.127","article-title":"Intrabursal injection of vascular endothelial growth factor trap in eCG-treated prepubertal rats inhibits proliferation and increases apoptosis of follicular cells involving the PI3K\/AKT signalling pathway.","volume":"93","author":"Abramovich","year":"2010","journal-title":"Fertil. Steril."},{"key":"2025102819390110300_R3","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/HUMREP\/13.3.651","article-title":"Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries.","volume":"13","author":"Agrawal","year":"1998","journal-title":"Hum. Reprod."},{"key":"2025102819390110300_R4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1006\/GYNO.2001.6287","article-title":"Thrombospondin-1 expression in epithelial ovarian carcinoma: association with p53 status, tumour angiogenesis and survival in platinum-treated patients.","volume":"82","author":"Alvarez","year":"2001","journal-title":"Gynecol. Oncol."},{"key":"2025102819390110300_R5","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/S0015-0282(02)04849-5","article-title":"Evaluation of the impact of laparoscopic ovarian drilling on Doppler indices of ovarian stromal blood flow, serum vascular endothelial growth factor and insulin-like growth factor-1 in women with polycystic ovary syndrome.","volume":"79","author":"Amin","year":"2003","journal-title":"Fertil. Steril."},{"key":"2025102819390110300_R6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/S00441-011-1251-1","article-title":"Vascular endothelial growth factor-A(165) (VEGF-A(165)) stimulates the in vitro development and oocyte competence of goat preantral follicles.","volume":"346","author":"Ara\u00fajo","year":"2011","journal-title":"Cell Tissue Res."},{"key":"2025102819390110300_R7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0945-053X(03)00005-2","article-title":"Thrombospondins 1 and 2 function as inhibitors of angiogenesis.","volume":"22","author":"Armstrong","year":"2003","journal-title":"Matrix Biol."},{"key":"2025102819390110300_R8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/IJWH.S11304","article-title":"Treatment options for polycystic ovary syndrome.","volume":"3","author":"Badawy","year":"2011","journal-title":"Int. J. Womens Health."},{"key":"2025102819390110300_R9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/J.MCE.2011.05.040","article-title":"The puzzles of the prokineticin 2 pathway in human reproduction.","volume":"346","author":"Balasubramanian","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"2025102819390110300_R10","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1093\/HUMREP\/DEQ005","article-title":"The non-ergot-derived dopamine agonist quinagolide in prevention of early ovarian hyperstimulation syndrome in IVF patients: a randomised, double-blind, placebo-controlled trial.","volume":"25","author":"Busso","year":"2010","journal-title":"Hum. Reprod."},{"key":"2025102819390110300_R11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1593\/neo.91880","article-title":"The thrombospondin-1 mimetic ABT-510 increases the uptake and effectiveness of cisplatin and paclitaxel in a mouse model of epithelial ovarian cancer.","volume":"12","author":"Campbell","year":"2010","journal-title":"Neoplasia"},{"key":"2025102819390110300_R12","doi-asserted-by":"publisher","first-page":"27 409","DOI":"10.1074\/JBC.M109.025460","article-title":"Suppression of tumour angiogenesis by Galpha(13) haploinsufficiency.","volume":"284","author":"Chen","year":"2009","journal-title":"J. Biol. Chem."},{"key":"2025102819390110300_R13","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1210\/EN.2004-1445","article-title":"Increased pituitary vascular endothelial growth factor-a in dopaminergic D2 receptor knockout female mice.","volume":"146","author":"Cristina","year":"2005","journal-title":"Endocrinology"},{"key":"2025102819390110300_R14","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/J.TRANSPROCEED.2008.02.065","article-title":"Remote ischemic preconditioning on neovascularization and follicle viability on ovary autotransplantation in rats.","volume":"40","author":"Damous","year":"2008","journal-title":"Transplant. Proc."},{"key":"2025102819390110300_R15","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/HUMUPD\/8.6.559","article-title":"Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review.","volume":"8","author":"Delvigne","year":"2002","journal-title":"Hum. Reprod. Update"},{"key":"2025102819390110300_R16","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1097\/GRF.0B013E3181F97A55","article-title":"Cryopreservation and transplantation of ovarian tissue.","volume":"53","author":"Donnez","year":"2010","journal-title":"Clin. Obstet. Gynecol."},{"key":"2025102819390110300_R17","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1093\/HUMREP\/17.11.2825","article-title":"Follicular administration of a cyclooxygenase inhibitor can prevent oocyte release without alteration of normal luteal function in rhesus monkeys.","volume":"17","author":"Duffy","year":"2002","journal-title":"Hum. Reprod."},{"key":"2025102819390110300_R18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1530\/ROR.0.0050012","article-title":"The human corpus luteum: remodelling during luteolysis and maternal recognition of pregnancy.","volume":"5","author":"Duncan","year":"2000","journal-title":"Rev. Reprod."},{"key":"2025102819390110300_R19","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1210\/EN.2007-1649","article-title":"Inhibition of vascular endothelial growth factor in the primate ovary up-regulates hypoxia-inducible factor-1alpha in the follicle and corpus luteum.","volume":"149","author":"Duncan","year":"2008","journal-title":"Endocrinology"},{"key":"2025102819390110300_R20","first-page":"34","article-title":"Luteal development and luteolysis in the primate corpus luteum.","volume":"6","author":"Duncan","year":"2009","journal-title":"Anim. Reprod."},{"key":"2025102819390110300_R21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/J.IJGO.2010.08.018","article-title":"Effect of laparoscopic ovarian drilling on vascular endothelial growth factor and ovarian stromal blood flow using 3-dimensional power Doppler.","volume":"112","author":"El Behery","year":"2011","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"2025102819390110300_R22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/J.FERTNSTERT.2011.09.024","article-title":"Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil. Steril."},{"key":"2025102819390110300_R23","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/J.RBMO.2011.03.013","article-title":"Ovarian drilling for surgical treatment of polycystic ovarian syndrome: a comprehensive review.","volume":"22","author":"Fernandez","year":"2011","journal-title":"Reprod. Biomed. Online"},{"key":"2025102819390110300_R24","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/S0002-9440(10)64322-2","article-title":"Differential expression of the angiogenic factor genes vascular endothelial growth factor (VEGF) and endocrine gland-derived VEGF in normal and polycystic human ovaries.","volume":"162","author":"Ferrara","year":"2003","journal-title":"Am. J. Pathol."},{"key":"2025102819390110300_R25","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1210\/EN.2009-0652","article-title":"Do animal models of polycystic ovary syndrome help to understand its pathogenesis and management? Yes, but their limitations should be recognized.","volume":"150","author":"Franks","year":"2009","journal-title":"Endocrinology"},{"key":"2025102819390110300_R26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/S10456-005-9004-Y","article-title":"Vascular morphogenesis in the primate ovary.","volume":"8","author":"Fraser","year":"2005","journal-title":"Angiogenesis"},{"key":"2025102819390110300_R27","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1071\/RD08272","article-title":"SRB Reproduction, Fertility and Development Award Lecture 2008. Regulation and manipulation of angiogenesis in the ovary and endometrium.","volume":"21","author":"Fraser","year":"2009","journal-title":"Reprod. Fertil. Dev."},{"key":"2025102819390110300_R28","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1210\/JC.2004-0843","article-title":"Localization and quantification of cyclic changes in the expression of endocrine gland vascular endothelial growth factor in the human corpus luteum.","volume":"90","author":"Fraser","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2025102819390110300_R29","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1530\/REP.1.01064","article-title":"Administration of vascular endothelial growth factor Trap during the \u2018post-angiogenic\u2019 period of the luteal phase causes rapid functional luteolysis and selective endothelial cell death in the marmoset.","volume":"132","author":"Fraser","year":"2006","journal-title":"Reproduction"},{"key":"2025102819390110300_R30","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/J.CONTRACEPTION.2010.04.020","article-title":"Inhibition of vascular endothelial growth factor during the postovulatory period prevents pregnancy in the marmoset.","volume":"82","author":"Fraser","year":"2010","journal-title":"Contraception"},{"key":"2025102819390110300_R31","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1210\/EN.2011-1688","article-title":"Inhibition of delta-like ligand 4 induces luteal hypervascularisation followed by functional and structural luteolysis in the primate ovary.","volume":"153","author":"Fraser","year":"2012","journal-title":"Endocrinology"},{"key":"2025102819390110300_R32","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1093\/HUMREP\/DER385","article-title":"Possible improvements in human ovarian grafting by various host and graft treatments.","volume":"27","author":"Friedman","year":"2012","journal-title":"Hum. Reprod."},{"key":"2025102819390110300_R33","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/J.FERTNSTERT.2009.03.029","article-title":"The measurements of RAGE, VEGF and AGEs in the plasma and follicular fluid of reproductive women: the influence of aging.","volume":"94","author":"Fujii","year":"2010","journal-title":"Fertil. Steril."},{"key":"2025102819390110300_R34","first-page":"CD007930","article-title":"Angiogenesis inhibitors for the treatment of ovarian cancer.","volume":"7","author":"Gaitskell","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"2025102819390110300_R35","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/J.FERTNSTERT.2010.09.044","article-title":"Endocrine gland-derived vascular endothelial growth factor concentrations in follicular fluid and serum may predict ovarian hyperstimulation syndrome in women undergoing controlled ovarian hyperstimulation.","volume":"95","author":"Gao","year":"2011","journal-title":"Fertil. Steril."},{"key":"2025102819390110300_R36","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1210\/EN.2009-0686","article-title":"Thrombospondin-1 inhibits angiogenesis and promotes follicular atresia in a novel in vitro angiogenesis assay.","volume":"151","author":"Garside","year":"2010","journal-title":"Endocrinology"},{"key":"2025102819390110300_R37","doi-asserted-by":"publisher","first-page":"5905","DOI":"10.1210\/EN.2010-0283","article-title":"A thrombospondin-mimetic peptide, ABT-898, suppresses angiogenesis and promotes follicular atresia in pre- and early-antral follicles in vivo.","volume":"151","author":"Garside","year":"2010","journal-title":"Endocrinology"},{"key":"2025102819390110300_R38","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1095\/BIOLREPROD57.2.478","article-title":"Role of prolactin in the regulation of macrophages and in the proliferative activity of vascular cells in newly formed and regressing rat corpora lutea.","volume":"57","author":"Gaytan","year":"1997","journal-title":"Biol. Reprod."},{"key":"2025102819390110300_R39","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1530\/REP.1.00555","article-title":"In vivo effects of pregnancy-associated plasma protein-A, activin-A and vascular endothelial growth factor on other follicular-fluid factors during follicle deviation in mares.","volume":"129","author":"Ginther","year":"2005","journal-title":"Reproduction"},{"key":"2025102819390110300_R40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/J.MCE.2005.01.005","article-title":"Prolactin-induced expression of vascular endothelial growth factor via Egr-1.","volume":"232","author":"Goldhar","year":"2005","journal-title":"Mol. Cell. Endocrinol."},{"key":"2025102819390110300_R41","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1210\/EN.2002-220204","article-title":"Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade.","volume":"143","author":"G\u00f3mez","year":"2002","journal-title":"Endocrinology"},{"key":"2025102819390110300_R42","doi-asserted-by":"publisher","first-page":"5400","DOI":"10.1210\/EN.2006-0657","article-title":"Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model.","volume":"147","author":"G\u00f3mez","year":"2006","journal-title":"Endocrinology"},{"key":"2025102819390110300_R43","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1210\/JC.2011-0075","article-title":"Evidences for the existence of a low dopaminergic tone in polycystic ovarian syndrome: implications for OHSS development and treatment.","volume":"96","author":"G\u00f3mez","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2025102819390110300_R44","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1158\/1078-0432.CCR-04-0056","article-title":"The relationship of molecular markers of p53 function and angiogenesis to prognosis of stage I epithelial ovarian cancer.","volume":"11","author":"Goodheart","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"2025102819390110300_R45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1477-7827-1-12","article-title":"Effects of deletion of the prolactin receptor on ovarian gene expression.","volume":"1","author":"Grosdemouge","year":"2003","journal-title":"Reprod. Biol. Endocrinol."},{"key":"2025102819390110300_R46","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/J.FERTNSTERT.2007.03.097","article-title":"Regulation of vascular endothelial growth factor-A and its soluble receptor sFlt-1 by luteinizing hormone in vivo: implication for ovarian follicle angiogenesis.","volume":"89","author":"Gutman","year":"2008","journal-title":"Fertil. Steril."},{"key":"2025102819390110300_R47","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1126\/SCIENCE.277.5322.48","article-title":"Signalling vascular morphogenesis and maintenance.","volume":"277","author":"Hanahan","year":"1997","journal-title":"Science"},{"key":"2025102819390110300_R48","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/MOLEHR\/5.12.1115","article-title":"Vascular endothelial growth factor (VEGF) and angiopoietin regulation by gonadotrophin and steroids in macaque granulosa cells during the peri-ovulatory interval.","volume":"5","author":"Hazzard","year":"1999","journal-title":"Mol. Hum. Reprod."},{"key":"2025102819390110300_R49","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1093\/MOLEHR\/6.11.993","article-title":"Changes in expression of vascular endothelial growth factor and angiopoietin-1 and -2 in the macaque corpus luteum during the menstrual cycle.","volume":"6","author":"Hazzard","year":"2000","journal-title":"Mol. Hum. Reprod."},{"key":"2025102819390110300_R50","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1095\/BIOLREPROD67.4.1305","article-title":"Injection of soluble vascular endothelial growth factor receptor 1 into the preovulatory follicle disrupts ovulation and subsequent luteal function in rhesus monkeys.","volume":"67","author":"Hazzard","year":"2002","journal-title":"Biol. Reprod."},{"key":"2025102819390110300_R51","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/NATURE05571","article-title":"Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis.","volume":"445","author":"Hellstr\u00f6m","year":"2007","journal-title":"Nature"},{"key":"2025102819390110300_R52","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1517\/14728222.2011.640319","article-title":"Therapies using anti-angiogenic peptide mimetics of thrombospondin-1.","volume":"15","author":"Henkin","year":"2011","journal-title":"Expert Opin. Ther. Targets"},{"key":"2025102819390110300_R53","doi-asserted-by":"publisher","first-page":"6030","DOI":"10.1158\/0008-5472.CAN-10-2719","article-title":"Biological roles of the Delta family Notch ligand Dll4 in tumour and endothelial cells in ovarian cancer.","volume":"71","author":"Hu","year":"2011","journal-title":"Cancer Res."},{"key":"2025102819390110300_R54","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/CR.2008.70","article-title":"Activation of the PI3K\/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma.","volume":"18","author":"Huang","year":"2008","journal-title":"Cell Res."},{"key":"2025102819390110300_R55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/J.1582-4934.2002.TB00307.X","article-title":"Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumour growth.","volume":"6","author":"Lawler","year":"2002","journal-title":"J. Cell. Mol. Med."},{"key":"2025102819390110300_R56","doi-asserted-by":"publisher","first-page":"e27990","DOI":"10.1371\/JOURNAL.PONE.0027990","article-title":"Modelling of human prokineticin receptors: interactions with novel small-molecule binders and potential off-target drugs.","volume":"6","author":"Levit","year":"2011","journal-title":"PLoS ONE"},{"key":"2025102819390110300_R57","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/S12032-009-9179-Y","article-title":"Effects of a selective cyclooxygenase-1 inhibitor in SKOV-3 ovarian carcinoma xenograft-bearing mice.","volume":"27","author":"Li","year":"2010","journal-title":"Med. Oncol."},{"key":"2025102819390110300_R58","doi-asserted-by":"publisher","first-page":"668","DOI":"10.3390\/IJMS12010668","article-title":"Combined effects of cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on ovarian carcinoma in vivo.","volume":"12","author":"Li","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"2025102819390110300_R59","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1073\/PNAS.0611206104","article-title":"Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting.","volume":"104","author":"Lobov","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025102819390110300_R60","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/JCB.20167","article-title":"Prolactin increases HO-1 expression and induces VEGF production in human macrophages.","volume":"93","author":"Malaguarnera","year":"2004","journal-title":"J. Cell. Biochem."},{"key":"2025102819390110300_R61","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/J.TEM.2006.12.002","article-title":"Potential roles of the prokineticins in reproduction.","volume":"18","author":"Maldonado-P\u00e9rez","year":"2007","journal-title":"Trends Endocrinol. Metab."},{"key":"2025102819390110300_R62","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1530\/REP-08-0117","article-title":"Vascular supply as a discriminating factor for pig preantral follicle selection.","volume":"137","author":"Martelli","year":"2009","journal-title":"Reproduction"},{"key":"2025102819390110300_R63","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/14647270601111239","article-title":"Review of the evidence base of strategies to prevent ovarian hyperstimulation syndrome.","volume":"10","author":"Mathur","year":"2007","journal-title":"Hum. Fertil."},{"key":"2025102819390110300_R64","doi-asserted-by":"publisher","DOI":"10.1007\/S00441-012-1330-Y","article-title":"The balance of pro-angiogenic and anti-angiogenic VEGFA isoforms regulate follicle development.","author":"McFee","year":"2012","journal-title":"Cell Tissue Res."},{"key":"2025102819390110300_R65","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/J.CANLET.2010.06.011","article-title":"Prokineticins in angiogenesis and cancer.","volume":"296","author":"Monnier","year":"2010","journal-title":"Cancer Lett."},{"key":"2025102819390110300_R66","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/S10815-008-9218-1","article-title":"Follicular fluid VEGF levels directly correlate with perifollicular blood flow in normoresponder patients undergoing IVF.","volume":"25","author":"Monteleone","year":"2008","journal-title":"J. Assist. Reprod. Genet."},{"key":"2025102819390110300_R67","doi-asserted-by":"publisher","DOI":"10.3109\/0284186X.2011.653437","article-title":"Survival for ovarian cancer in europe: the across-country variation did not shrink in the past decade.","author":"Oberaigner","year":"2012","journal-title":"Acta Oncol."},{"key":"2025102819390110300_R68","doi-asserted-by":"publisher","first-page":"7463","DOI":"10.1158\/0008-5472.CAN-11-2449","article-title":"PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment.","volume":"71","author":"Obermajer","year":"2011","journal-title":"Cancer Res."},{"key":"2025102819390110300_R69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/ER.2008-0030","article-title":"Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review.","volume":"30","author":"Palomba","year":"2009","journal-title":"Endocr. Rev."},{"key":"2025102819390110300_R70","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/J.FERTNSTERT.2011.09.020","article-title":"Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotrophin-stimulated in vitro fertilisation cycles: a randomised, controlled trial.","volume":"96","author":"Palomba","year":"2011","journal-title":"Fertil. Steril."},{"key":"2025102819390110300_R71","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/J.RBMO.2010.01.007","article-title":"Role of vascular endothelial growth factor in women with PCO and PCOS: a systematic review.","volume":"20","author":"Peitsidis","year":"2010","journal-title":"Reprod. Biomed. Online"},{"key":"2025102819390110300_R72","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3109\/09513590903215516","article-title":"LH supplementation in down-regulated women undergoing assisted reproduction with baseline low serum LH levels.","volume":"26","author":"Pezzuto","year":"2010","journal-title":"Gynecol. Endocrinol."},{"key":"2025102819390110300_R73","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1093\/HUMREP\/DER349","article-title":"Ovarian hyperstimulation syndrome is correlated with a reduction of soluble VEGF receptor protein level and a higher amount of VEGF-A.","volume":"27","author":"Pietrowski","year":"2012","journal-title":"Hum. Reprod."},{"key":"2025102819390110300_R74","doi-asserted-by":"publisher","DOI":"10.1530\/REP-11-0091","article-title":"Ovarian VEGF165b expression regulates follicular development, corpus luteum function and fertility.","author":"Qiu","year":"2012","journal-title":"Reproduction"},{"key":"2025102819390110300_R75","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/J.FERTNSTERT.2007.09.028","article-title":"Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model.","volume":"90","author":"Quintana","year":"2008","journal-title":"Fertil. Steril."},{"key":"2025102819390110300_R76","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S1472-6483(10)60041-7","article-title":"Symposium: update on prediction and management of OHSS. Genetics of ovarian hyperstimulation syndrome.","volume":"19","author":"Rizk","year":"2009","journal-title":"Reprod. Biomed. Online"},{"key":"2025102819390110300_R77","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1093\/MOLEHR\/GAM066","article-title":"Regulation of tight-junction proteins occludin and claudin 5 in the primate ovary during the ovulatory cycle and after inhibition of vascular endothelial growth factor.","volume":"13","author":"Rodewald","year":"2007","journal-title":"Mol. Hum. Reprod."},{"key":"2025102819390110300_R78","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1093\/HUMREP\/DEN479","article-title":"Molecular mechanisms of ovarian hyperstimulation syndrome: paracrine reduction of endothelial claudin 5 by hCG in vitro is associated with increased endothelial permeability.","volume":"24","author":"Rodewald","year":"2009","journal-title":"Hum. Reprod."},{"key":"2025102819390110300_R79","doi-asserted-by":"publisher","DOI":"10.1016\/J.CLLC.2011.12.001","article-title":"Beyond Bevacizumab: anti-angiogenic agents.","author":"Rogosin","year":"2012","journal-title":"Clin. Lung Cancer"},{"key":"2025102819390110300_R80","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/J.YGYNO.2008.11.030","article-title":"Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status and angiogenic marker expression: a Gynecologic Oncology Group study.","volume":"112","author":"Rubatt","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"2025102819390110300_R81","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1530\/JOE-10-0357","article-title":"Stimulation of tube formation mediated through the prostaglandin EP2 receptor in rat luteal endothelial cells.","volume":"209","author":"Sakurai","year":"2011","journal-title":"J. Endocrinol."},{"key":"2025102819390110300_R82","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/J.ULTRASMEDBIO.2010.10.013","article-title":"Imaging of the ovine corpus luteum microcirculation with contrast ultrasound.","volume":"37","author":"Sboros","year":"2011","journal-title":"Ultrasound Med. Biol."},{"key":"2025102819390110300_R83","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1477-7827-7-78","article-title":"LH pulse frequency and the emergence and growth of ovarian antral follicular waves in the ewe during the luteal phase of the oestrous cycle.","volume":"7","author":"Seekallu","year":"2009","journal-title":"Reprod. Biol. Endocrinol."},{"key":"2025102819390110300_R84","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1016\/J.FERTNSTERT.2009.02.059","article-title":"Thiazolidinediones decrease vascular endothelial growth factor (VEGF) production by human luteinised granulosa cells in vitro.","volume":"93","author":"Shah","year":"2010","journal-title":"Fertil. Steril."},{"key":"2025102819390110300_R85","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1089\/TEN.TEA.2011.0204","article-title":"Fibrin encapsulation and vascular endothelial growth factor delivery promotes ovarian graft survival in mice.","volume":"17","author":"Shikanov","year":"2011","journal-title":"Tissue Eng. Part A"},{"key":"2025102819390110300_R86","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/J.FERTNSTERT.2010.12.036","article-title":"Granulocyte colony-stimulating factor in conjunction with vascular endothelial growth factor maintains primordial follicle numbers in transplanted mouse ovaries.","volume":"95","author":"Skaznik-Wikiel","year":"2011","journal-title":"Fertil. Steril."},{"key":"2025102819390110300_R87","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1210\/JC.2006-2846","article-title":"Insulin and insulin-like growth factor stimulation of vascular endothelial growth factor production by luteinised granulosa cells: comparison between polycystic ovarian syndrome (PCOS) and non-PCOS women.","volume":"92","author":"Stanek","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2025102819390110300_R88","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1210\/ER.2006-0022","article-title":"The molecular control of corpus luteum formation, function and regression.","volume":"28","author":"Stocco","year":"2007","journal-title":"Endocr. Rev."},{"key":"2025102819390110300_R89","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.1073\/PNAS.0611177104","article-title":"The Notch ligand-like 4 negatively regulates endothelial tip cell formation and vessel branching.","volume":"104","author":"Suchting","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025102819390110300_R90","doi-asserted-by":"publisher","first-page":"6141","DOI":"10.1210\/JC.2005-0643","article-title":"Angiogenesis in the human corpus luteum: changes in expression of angiopoietins in the corpus luteum throughout the menstrual cycle and in early pregnancy.","volume":"90","author":"Sugino","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2025102819390110300_R91","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1093\/HUMREP\/DER120","article-title":"Do women with ovaries of polycystic morphology without any other features of PCOS benefit from short-term metformin co-treatment during IVF? A double-blind, placebo-controlled, randomised trial.","volume":"26","author":"Swanton","year":"2011","journal-title":"Hum. Reprod."},{"key":"2025102819390110300_R92","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/J.JINORGBIO.2010.03.010","article-title":"New platinum\u2013oxicam complexes as anti-cancer drugs. Synthesis, characterization, release studies from smart hydrogels, evaluation of reactivity with selected proteins and cytotoxic activity in vitro.","volume":"104","author":"Tamasi","year":"2010","journal-title":"J. Inorg. Biochem."},{"key":"2025102819390110300_R93","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/HUMUPD\/DMM048","article-title":"Cellular and molecular aspects of ovarian follicle ageing.","volume":"14","author":"Tatone","year":"2008","journal-title":"Hum. Reprod. Update"},{"key":"2025102819390110300_R94","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/IGC.0B013E31823C6EFD","article-title":"Anti-angiogenic agents in combination with chemotherapy for the treatment of epithelial ovarian cancer.","volume":"22","author":"Teoh","year":"2012","journal-title":"Int. J. Gynecol. Cancer"},{"key":"2025102819390110300_R95","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1210\/JC.84.9.3030","article-title":"Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome.","volume":"84","author":"Thierry van Dessel","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2025102819390110300_R96","first-page":"468","article-title":"Gonadotrophins and female sex steroid hormones in cyst fluid and serum from patients with ovarian tumours.","volume":"29","author":"Thomas","year":"2008","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"2025102819390110300_R97","first-page":"CD006105","article-title":"Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.","volume":"15","author":"Tso","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"2025102819390110300_R98","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/IJC.24757","article-title":"Cyclooxygenase-2 inhibition inhibits PI3K\/AKT kinase activity in epithelial ovarian cancer.","volume":"126","author":"Uddin","year":"2010","journal-title":"Int. J. Cancer"},{"key":"2025102819390110300_R99","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.1210\/EN.2011-1077","article-title":"Prevention of the onset of ovarian hyperstimulation syndrome (OHSS) in the rat after ovulation induction with a low molecular weight agonist of the LH receptor compared with hCG and rec-LH.","volume":"152","author":"van de Lagemaat","year":"2011","journal-title":"Endocrinology"},{"key":"2025102819390110300_R100","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/MOLEHR\/GAN040","article-title":"Human chorionic gonadotrophin up-regulates hypoxia inducible factor-1 alpha in luteinised granulosa cells: implications for the hormonal regulation of vascular endothelial growth factor A in the human corpus luteum.","volume":"14","author":"van den Driesche","year":"2008","journal-title":"Mol. Hum. Reprod."},{"key":"2025102819390110300_R101","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1210\/EN.2009-0107","article-title":"A unique human chorionic gonadotrophin antagonist suppresses ovarian hyperstimulation syndrome in rats.","volume":"150","author":"Vardhana","year":"2009","journal-title":"Endocrinology"},{"key":"2025102819390110300_R102","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1016\/J.FERTNSTERT.2009.01.085","article-title":"Low-dose aspirin therapy to prevent ovarian hyperstimulation syndrome.","volume":"93","author":"V\u00e1rnagy","year":"2010","journal-title":"Fertil. Steril."},{"key":"2025102819390110300_R103","doi-asserted-by":"publisher","first-page":"7293","DOI":"10.1038\/SJ.ONC.1204896","article-title":"p73 overexpression increases VEGF and reduces thrombospondin-1 production: implications for tumour angiogenesis.","volume":"20","author":"Vikhanskaya","year":"2001","journal-title":"Oncogene"},{"key":"2025102819390110300_R104","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1093\/MOLEHR\/7.11.1033","article-title":"Prolactin receptor gene expression and immunolocalisation of the prolactin receptor in human luteinised granulosa cells.","volume":"7","author":"Vlahos","year":"2001","journal-title":"Mol. Hum. Reprod."},{"key":"2025102819390110300_R105","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1210\/JC.85.11.4302","article-title":"Angiogenesis in the human corpus luteum: localisation and changes in angiopoietins, tie-2 and vascular endothelial growth factor messenger ribonucleic acid.","volume":"85","author":"Wulff","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2025102819390110300_R106","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1210\/EN.143.7.2797","article-title":"Prevention of thecal angiogenesis, antral follicular growth and ovulation in the primate by treatment with vascular endothelial growth factor Trap R1R2.","volume":"143","author":"Wulff","year":"2002","journal-title":"Endocrinology"},{"key":"2025102819390110300_R107","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/CNCR.22854","article-title":"Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers.","volume":"110","author":"Xin","year":"2007","journal-title":"Cancer"},{"key":"2025102819390110300_R108","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/BF02940318","article-title":"Anti-tumour effect of non-steroidal anti-inflammatory drugs on human ovarian cancers.","volume":"13","author":"Xin","year":"2007","journal-title":"Pathol. Oncol. Res."},{"key":"2025102819390110300_R109","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1095\/BIOLREPROD.104.037143","article-title":"Local delivery of angiopoietin-2 into the preovulatory follicle terminates the menstrual cycle in rhesus monkeys.","volume":"72","author":"Xu","year":"2005","journal-title":"Biol. Reprod."},{"key":"2025102819390110300_R110","doi-asserted-by":"publisher","first-page":"7243","DOI":"10.1158\/1078-0432.CCR-07-1393","article-title":"Delta-like 4\/Notch signalling and its therapeutic implications.","volume":"13","author":"Yan","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"2025102819390110300_R111","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/HUMUPD\/DMQ006","article-title":"Can dopamine agonists reduce the incidence and severity of OHSS in IVF\/ICSI treatment cycles? A systematic review and meta-analysis.","volume":"16","author":"Youssef","year":"2010","journal-title":"Hum. Reprod. Update"},{"key":"2025102819390110300_R112","first-page":"264","article-title":"Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma.","volume":"9","author":"Zhang","year":"2003","journal-title":"Clin. Cancer Res."}],"container-title":["Reproduction, Fertility and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/rd\/article-pdf\/25\/2\/362\/310224\/rd12112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/rd\/article-pdf\/25\/2\/362\/310224\/rd12112.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T23:39:10Z","timestamp":1761694750000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/rd\/article\/25\/2\/362\/49948\/Targeting-angiogenesis-in-the-pathological-ovary"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,27]]},"references-count":112,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,1,29]]}},"URL":"https:\/\/doi.org\/10.1071\/rd12112","relation":{},"ISSN":["1031-3613","1448-5990"],"issn-type":[{"value":"1031-3613","type":"print"},{"value":"1448-5990","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,27]]}}}